Cambridge Reclaims Top Lab Spot With $438M Deal
Cambridge has reclaimed the mantle of highest price ever paid for lab space in Greater Boston, with an investor paying $1,880 per square foot for a stake in a 3-year-old Kendall Square development.
German Biopharma Company Buys Shire’s Milford Plant
German pharmaceutical contract development and manufacturing company Rentschler Biopharma SE has completed its purchase of a Shire manufacturing plant in Milford.
When a Merger Means Growth
A merger between the second and sixth largest employers in Massachusetts’ all-important life science industry typically would cause indigestion in commercial real estate and economic development circles.
Biotech and Pharma Are Big Business for Massachusetts
More than one-third of all venture capital money invested in biopharmaceutical companies last year went to Massachusetts companies, with the bulk of those dollars headed to companies in Cambridge and nearby, according to a new industry report.
REIT Makes $249M Bet On Life Science In Lexington
A California health care REIT has paid $228 million for the 400,000-square-foot Hayden Research Campus in Lexington and is expected to invest in a planned 209,000-square-foot speculative lab building that would expand the Route 128 market’s growing life science cluster.
Shire Opening Research Center In Kendall Square
Irish pharmaceutical company Shire plc has leased 343,000 square feet at 500 Kendall St. in Cambridge for a new rare disease research hub.
Shire Adds Another 200K SF In Lexington
Irish pharmaceutical giant Shire has leased an additional 200,000 square feet in Lexington where it’s expanding its office and lab operations on Hayden Avenue.
Shire Commits To Expand In Lexington With 177K Lease
Irish pharmaceutical giant Shire has leased nearly...
